Recto, Rudita .

HRN: 14-79-75  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/12/2022
CEFTRIAXONE 1G (VIAL)
09/12/2022
09/18/2022
IVT
2g
OD
Presumptive TB
Waiting Final Action 
07/27/2023
CEFTRIAXONE 1G (VIAL)
07/27/2023
08/03/2023
IV
2g
Q24h
Cap-hr, T/c Septic Encephalopathy From Cap-hr, S/p Cvd Infarct
Waiting Final Action 
07/28/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/28/2023
08/04/2023
IV
4.5g
Q6hour
Empiric
Waiting Final Action 
07/28/2023
AZITHROMYCIN 500MG TABLET (TAB)
07/28/2023
08/01/2023
PO
500mg
OD
Empiric
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: